×
返回 Agenda
Session 8: Hot Topics
Session Chair(s)
Emily Place, PhD, MPH
Senior Consultant
Aclairo Pharmaceutical Development Group, United States
Ronald Wange, PhD
Associate Director for Pharm/Tox OND
FDA, United States
Session 8: Hot Topics
Speaker(s)
Presentation Title: Harnessing RNA Exon Editing to Rewrite the Underlying Causes of Genetic Diseases
Robert Bell, PhD
Ascidian, United States
CSO
siRNA Manufacturing with Engineered Enzymes
Stefan Lutz, PhD
Codexis, Inc. , United States
SVP, Head of Research
Confusion Arising from a Shared Vocabulary: What does “Platform” Really Mean?
Ronald Wange, PhD
FDA, United States
Associate Director for Pharm/Tox OND